Erin R Ewald1, Gary S Wand2, Fayaz Seifuddin1, Xiaoju Yang3, Kellie L Tamashiro1, James B Potash4, Peter Zandi5, Richard S Lee6. 1. Johns Hopkins Mood Disorders Center, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA; Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA. 2. Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA; Division of Endocrinology of the Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. 3. Division of Endocrinology of the Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. 4. Department of Psychiatry, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA. 5. Johns Hopkins Mood Disorders Center, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA; Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA; Department of Mental Health of the Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA. 6. Johns Hopkins Mood Disorders Center, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA; Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA. Electronic address: richardlee@jhmi.edu.
Abstract
BACKGROUND: Epigenetic studies that utilize peripheral tissues to identify molecular substrates of neuropsychiatric disorders rely on the assumption that disease-relevant, cellular alterations that occur in the brain are mirrored and detectable in peripheral tissues such as blood. We sought to test this assumption by using a mouse model of Cushing's disease and asking whether epigenetic changes induced by glucocorticoids can be correlated between these tissue types. METHODS: Mice were treated with different doses of glucocorticoids in their drinking water for four weeks to assess gene expression and DNA methylation (DNAm) changes in the stress response gene Fkbp5. RESULTS: Significant linear relationships were observed between DNAm and four-week mean plasma corticosterone levels for both blood (R(2)=0.68, P=7.1×10(-10)) and brain (R(2)=0.33, P=0.001). Further, degree of methylation change in blood correlated significantly with both methylation (R(2)=0.49, P=2.7×10(-5)) and expression (R(2)=0.43, P=3.5×10(-5)) changes in hippocampus, with the notable observation that methylation changes occurred at different intronic regions between blood and brain tissues. CONCLUSION: Although our findings are limited to several intronic CpGs in a single gene, our results demonstrate that DNA from blood can be used to assess dynamic, glucocorticoid-induced changes occurring in the brain. However, for such correlation analyses to be effective, tissue-specific locations of these epigenetic changes may need to be considered when investigating brain-relevant changes in peripheral tissues.
BACKGROUND: Epigenetic studies that utilize peripheral tissues to identify molecular substrates of neuropsychiatric disorders rely on the assumption that disease-relevant, cellular alterations that occur in the brain are mirrored and detectable in peripheral tissues such as blood. We sought to test this assumption by using a mouse model of Cushing's disease and asking whether epigenetic changes induced by glucocorticoids can be correlated between these tissue types. METHODS:Mice were treated with different doses of glucocorticoids in their drinking water for four weeks to assess gene expression and DNA methylation (DNAm) changes in the stress response gene Fkbp5. RESULTS: Significant linear relationships were observed between DNAm and four-week mean plasma corticosterone levels for both blood (R(2)=0.68, P=7.1×10(-10)) and brain (R(2)=0.33, P=0.001). Further, degree of methylation change in blood correlated significantly with both methylation (R(2)=0.49, P=2.7×10(-5)) and expression (R(2)=0.43, P=3.5×10(-5)) changes in hippocampus, with the notable observation that methylation changes occurred at different intronic regions between blood and brain tissues. CONCLUSION: Although our findings are limited to several intronic CpGs in a single gene, our results demonstrate that DNA from blood can be used to assess dynamic, glucocorticoid-induced changes occurring in the brain. However, for such correlation analyses to be effective, tissue-specific locations of these epigenetic changes may need to be considered when investigating brain-relevant changes in peripheral tissues.
Authors: Alan P Boyle; Sean Davis; Hennady P Shulha; Paul Meltzer; Elliott H Margulies; Zhiping Weng; Terrence S Furey; Gregory E Crawford Journal: Cell Date: 2008-01-25 Impact factor: 41.582
Authors: Gabriela M Wochnik; Joëlle Rüegg; G Alexander Abel; Ulrike Schmidt; Florian Holsboer; Theo Rein Journal: J Biol Chem Date: 2004-12-09 Impact factor: 5.157
Authors: Ulrike A Nuber; Skirmantas Kriaucionis; Tim C Roloff; Jacky Guy; Jim Selfridge; Christine Steinhoff; Ralph Schulz; Bettina Lipkowitz; H Hilger Ropers; Megan C Holmes; Adrian Bird Journal: Hum Mol Genet Date: 2005-07-07 Impact factor: 6.150
Authors: Elisabeth B Binder; Daria Salyakina; Peter Lichtner; Gabriele M Wochnik; Marcus Ising; Benno Pütz; Sergi Papiol; Shaun Seaman; Susanne Lucae; Martin A Kohli; Thomas Nickel; Heike E Künzel; Brigitte Fuchs; Matthias Majer; Andrea Pfennig; Nikola Kern; Jürgen Brunner; Sieglinde Modell; Thomas Baghai; Tobias Deiml; Peter Zill; Brigitta Bondy; Rainer Rupprecht; Thomas Messer; Oliver Köhnlein; Heike Dabitz; Tanja Brückl; Nina Müller; Hildegard Pfister; Roselind Lieb; Jakob C Mueller; Elin Lõhmussaar; Tim M Strom; Thomas Bettecken; Thomas Meitinger; Manfred Uhr; Theo Rein; Florian Holsboer; Bertram Muller-Myhsok Journal: Nat Genet Date: 2004-11-21 Impact factor: 38.330
Authors: Nadine Provençal; Janine Arloth; Annamaria Cattaneo; Christoph Anacker; Nadia Cattane; Tobias Wiechmann; Simone Röh; Maik Ködel; Torsten Klengel; Darina Czamara; Nikola S Müller; Jari Lahti; Katri Räikkönen; Carmine M Pariante; Elisabeth B Binder Journal: Proc Natl Acad Sci U S A Date: 2019-08-09 Impact factor: 11.205
Authors: Fayaz Seifuddin; Gary Wand; Olivia Cox; Mehdi Pirooznia; Laura Moody; Xiaoju Yang; Jonathan Tai; Gretha Boersma; Kellie Tamashiro; Peter Zandi; Richard Lee Journal: Epigenetics Date: 2017-05-30 Impact factor: 4.528
Authors: Richard S Lee; Pamela B Mahon; Peter P Zandi; Mary E McCaul; Xiaoju Yang; Utsav Bali; Gary S Wand Journal: Psychoneuroendocrinology Date: 2018-07-04 Impact factor: 4.905
Authors: Huiyan Huang; Yong Zhu; Melissa N Eliot; Valerie S Knopik; John E McGeary; Mary A Carskadon; Anne C Hart Journal: Sleep Date: 2017-06-01 Impact factor: 5.849
Authors: Eugenia Resmini; Alicia Santos; Anna Aulinas; Susan M Webb; Yolanda Vives-Gilabert; Olivia Cox; Gary Wand; Richard S Lee Journal: Endocrine Date: 2016-09-23 Impact factor: 3.633
Authors: Johanna Klinger-König; Johannes Hertel; Sandra Van der Auwera; Stefan Frenzel; Liliane Pfeiffer; Melanie Waldenberger; Janine Golchert; Alexander Teumer; Matthias Nauck; Georg Homuth; Henry Völzke; Hans J Grabe Journal: Neuropsychopharmacology Date: 2019-01-23 Impact factor: 7.853